HHS Names First Director of the Biomedical Advanced Research Development... ( WASHINGTON April 14 -- The Depar...)

HHS Names First Director of the Biomedical Advanced Research Development Authority

Date:4/14/2008

WASHINGTON, April 14 /PRNewswire-USNewswire/ -- The Department of Health and Human Services today announced the selection of Robin Robinson, Ph.D., as the first director of the Biomedical Advanced Research Development Authority (BARDA), which was established in 2007 in the HHS Office of the Assistant Secretary for Preparedness and Response.

"Robin is an excellent choice for BARDA Director," said HHS Assistant Secretary for Preparedness and Response RADM Craig Vanderwagen, M.D., USPHS. "Robin was the strongest candidate to emerge in our nationwide search, and his extensive experience in industry and government concretely demonstrates his ability to succeed."

In his current role as Deputy Director of BARDA's Influenza and Emerging Disease Program, Dr. Robinson led the successful development, procurement and stockpiling of the world's first H5N1 influenza vaccine approved for human use, which was cited by Time Magazine as the number one medical breakthrough in 2007.

"I am delighted that Robin Robinson has been named as the Director of BARDA. Robin brings scientific, public health and industry experience to a position that is critical to our emergency preparedness strategy," said Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. "His leadership qualities, keen perspective and broad expertise will contribute greatly to the success of the program."

BARDA was established in the HHS Office of the Assistant Secretary for Preparedness and Response in 2007. BARDA manages Project BioShield, which includes the procurement and advanced development of medical countermeasures for chemical, biological, radiological, nuclear agents, as well as manages the advanced development and procurement of medical countermeasures for pandemic influenza and other emerging infectious diseases that fall outside the auspices of Project BioShield.

Note: All HHS press r
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
2. Mediware Names Thomas K. Mann Chief Executive Officer
3. Cleveland-based Health Care Tech Company Within3 Names New CEO
4. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
5. Patient Safety Authority Board of Directors Names Infection Advisory Panel
6. Hooper Holmes Names Chris Behling President of Health & Wellness Division
7. MDMA Names New Director of Federal Affairs
8. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
9. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
10. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
11. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings

Post Your Comments:

HHS Names First Director of the Biomedical Advanced Research Development...( WASHINGTON April 14 -- The Depar...),Health